SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
View HTML
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
View HTML
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
View HTML
25

Notification filed by National Securities Exchange to report the removal from listing and registration on a national securities exchange

Other
View HTML
25

Notification filed by National Securities Exchange to report the removal from listing and registration on a national securities exchange

Other
View HTML
25-NSE

25-NSE

Other
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe